Replies to post #361577 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

"Out of a study of 53 patients receiving remdesivir, 32 patients (60%) experienced adverse events during follow-up [5].Oct 24, 2020"

Guess what?

Out of a study of 29 patients who received brilacidin, 29 (100%) experienced adverse events during follow-up:

https://clinicaltrials.gov/ct2/show/results/NCT02324335?term=brilacidin&draw=1&rank=1

And guess what? Out of a study of 159 patients on brilacidin, 134 (85%) experienced adverse events during follow-up:



So, what's your point?